相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical evaluation of the antifungal effect of sertraline in the treatment of cryptococcal meningitis in HIV patients: a single Mexican center experience
Hiram Villanueva-Lozano et al.
INFECTION (2018)
SuperDRUG2: a one stop resource for approved/marketed drugs
Vishal B. Siramshetty et al.
NUCLEIC ACIDS RESEARCH (2018)
Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics
Craig R. MacNair et al.
NATURE COMMUNICATIONS (2018)
Systematic analyses of drugs and disease indications in RepurposeDB reveal pharmacological, biological and epidemiological factors influencing drug repositioning
Khader Shameer et al.
BRIEFINGS IN BIOINFORMATICS (2018)
Screening a repurposing library for potentiators of antibiotics against Staphylococcus aureus biofilms
Freija Van den Driessche et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors
Andrea Astolfi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
The Drug Repurposing Hub: a next-generation drug library and information resource
Steven M. Corsello et al.
NATURE MEDICINE (2017)
On the Integration of In Silico Drug Design Methods for Drug Repurposing
Eric March-Vila et al.
FRONTIERS IN PHARMACOLOGY (2017)
A standard database for drug repositioning
Adam S. Brown et al.
SCIENTIFIC DATA (2017)
Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance
Jonathan M. Stokes et al.
NATURE MICROBIOLOGY (2017)
Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics
J. Javier Hernandez et al.
FRONTIERS IN ONCOLOGY (2017)
Tamoxifen Pharmacovigilance: Implications for Safe Use in the Future
Demetra Antimisiaris et al.
CONSULTANT PHARMACIST (2017)
Synergistic drug combination effectively blocks Ebola virus infection
Wei Sun et al.
ANTIVIRAL RESEARCH (2017)
Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives
Sebastian M. Gygli et al.
FEMS MICROBIOLOGY REVIEWS (2017)
The SIDER database of drugs and side effects
Michael Kuhn et al.
NUCLEIC ACIDS RESEARCH (2016)
Zika Virus: Rapid Spread in the Western Hemisphere
Lin H. Chen et al.
ANNALS OF INTERNAL MEDICINE (2016)
New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria
Jourdan A. Andersson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
Nicholas J. Barrows et al.
CELL HOST & MICROBE (2016)
Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their Growth
Hengli Tang et al.
CELL STEM CELL (2016)
Drug combination therapy increases successful drug repositioning
Wei Sun et al.
DRUG DISCOVERY TODAY (2016)
Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study
Joshua Rhein et al.
LANCET INFECTIOUS DISEASES (2016)
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
Yi-Yun Liu et al.
LANCET INFECTIOUS DISEASES (2016)
Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen
Miao Xu et al.
NATURE MEDICINE (2016)
Identification of new drug candidates against Borrelia burgdorferi using high-throughput screening
Venkata Raveendra Pothineni et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Hospital transmitted Candida auris infections confirmed in the US
Michael McCarthy
BMJ-BRITISH MEDICAL JOURNAL (2016)
Computational Discovery of Putative Leads for Drug Repositioning through Drug-Target Interaction Prediction
Edgar D. Coelho et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
A Multilayer Network Approach for Guiding Drug Repositioning in Neglected Diseases
Ariel Jose Berenstein et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Hospital transmitted Candida auris infections confirmed in the US
Michael McCarthy
BMJ-BRITISH MEDICAL JOURNAL (2016)
Drug resistance in eukaryotic microorganisms
Alan H. Fairlamb et al.
NATURE MICROBIOLOGY (2016)
Unconventional screening approaches for antibiotic discovery
Maya A. Farha et al.
ANTIMICROBIAL THERAPEUTICS REVIEWS (2015)
Computational and Practical Aspects of Drug Repositioning
Tudor I. Oprea et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2015)
Structure-activity studies of Wnt/β-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposure
Robert A. Mook et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
FDA's Expedited Approval Mechanisms for New Drug Products
Erin E. Kepplinger
BIOTECHNOLOGY LAW REPORT (2015)
Antimicrobial interactions: mechanisms and implications for drug discovery and resistance evolution
Tobias Bollenbach
CURRENT OPINION IN MICROBIOLOGY (2015)
Repurposing Non-Antimicrobial Drugs and Clinical Molecules to Treat Bacterial Infections
Waleed Younis et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Drug repositioning and repurposing: terminology and definitions in literature
Joris Langedijk et al.
DRUG DISCOVERY TODAY (2015)
Open innovation platforms to boost pharmaceutical collaborations: evaluating external compounds for desired biological activity
Niclas Nilsson et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Inhibitory effects of niclosamide on inflammation and migration of fibroblast-like synoviocytes from patients with rheumatoid arthritis
Liuqin Liang et al.
INFLAMMATION RESEARCH (2015)
Systematic Drug Repositioning for a Wide Range of Diseases with Integrative Analyses of Phenotypic and Molecular Data
Hiroaki Iwata et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)
Temporal and spatial analysis of the 2014-2015 Ebola virus outbreak in West Africa
Miles W. Carroll et al.
NATURE (2015)
An analysis of the attrition of drug candidates from four major pharmaceutical companies
Michael J. Waring et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Antagonism screen for inhibitors of bacterial cell wall biogenesis uncovers an inhibitor of undecaprenyl diphosphate synthase
Maya A. Farha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection
Shanshan He et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity
Lisa M. Johansen et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Auranofin: Repurposing an Old Drug for a Golden New Age
Christine Roder et al.
DRUGS IN R&D (2015)
Incentives to Repurpose Existing Drugs for Orphan Indications
Annette K. Kwok et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
New drug target in protozoan parasites: the role of thioredoxin reductase
Rosa M. Andrade et al.
FRONTIERS IN MICROBIOLOGY (2015)
Evaluation of Ebola Virus Inhibitors for Drug Repurposing
Peter B. Madrid et al.
ACS INFECTIOUS DISEASES (2015)
Design and evaluation of injectable niclosamide nanocrystals prepared by wet media milling technique
Yanghuan Ye et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2015)
Clinically Relevant Growth Conditions Alter Acinetobacter baumannii Antibiotic Susceptibility and Promote Identification of Novel Antibacterial Agents
Jennifer M. Colquhoun et al.
PLOS ONE (2015)
Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
Julie Dyall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Confronting the challenges of discovery of novel antibacterial agents
Sheo B. Singh
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Update on the antibiotic resistance crisis
Gian Maria Rossolini et al.
CURRENT OPINION IN PHARMACOLOGY (2014)
Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms
Nicolas Delattin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Drug repurposing: mining protozoan proteomes for targets of known bioactive compounds
Adam Sateriale et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2014)
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Frederic Ariey et al.
NATURE (2014)
Opening the lead generation toolbox
Peter B. Simpson et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
2013 FDA drug approvals
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2014)
A Case of Severe Ebola Virus Infection Complicated by Gram-Negative Septicemia
Benno Kreuels et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
PubChem BioAssay: 2014 update
Yanli Wang et al.
NUCLEIC ACIDS RESEARCH (2014)
The ChEMBL bioactivity database: an update
A. Patricia Bento et al.
NUCLEIC ACIDS RESEARCH (2014)
Whole Animal Automated Platform for Drug Discovery against Multi-Drug Resistant Staphylococcus aureus
Rajmohan Rajamuthiah et al.
PLOS ONE (2014)
Discovery and preclinical development of new antibiotics
Diarmaid Hughes et al.
UPSALA JOURNAL OF MEDICAL SCIENCES (2014)
Synergy Testing of FDA-Approved Drugs Identifies Potent Drug Combinations against Trypanosoma cruzi
Joseph D. Planer et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Discovery of a small molecule that inhibits bacterial ribosome biogenesis
Jonathan M. Stokes et al.
ELIFE (2014)
Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs
Jennifer Kouznetsova et al.
EMERGING MICROBES & INFECTIONS (2014)
Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent
Pan Pantziarka et al.
ECANCERMEDICALSCIENCE (2014)
Inhibition of WTA Synthesis Blocks the Cooperative Action of PBPs and Sensitizes MRSA to β-Lactams
Maya A. Farha et al.
ACS CHEMICAL BIOLOGY (2013)
Adenylate Kinase Release as a High-Throughput-Screening-Compatible Reporter of Bacterial Lysis for Identification of Antibacterial Agents
Anna C. Jacobs et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
New Life for an Old Drug: the Anthelmintic Drug Niclosamide Inhibits Pseudomonas aeruginosa Quorum Sensing
Francesco Imperi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
A Reprofiled Drug, Auranofin, Is Effective against Metronidazole-Resistant Giardia lamblia
Noa Tejman-Yarden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
High-Throughput Screening of a Collection of Known Pharmacologically Active Small Compounds for Identification of Candida albicans Biofilm Inhibitors
Samuel A. Siles et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Drug Repurposing Screen Reveals FDA-Approved Inhibitors of Human HMG-CoA Reductase and Isoprenoid Synthesis That Block Cryptosporidium parvum Growth
Kovi Bessoff et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Discovery of Antivirulence Agents against Methicillin-Resistant Staphylococcus aureus
Varandt Khodaverdian et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Synthesis and Anti-Plasmodium Activity of Benzimidazole Analogues Structurally Related to Astemizole
Gheorghe Roman et al.
CHEMMEDCHEM (2013)
Shifting from the single to the multitarget paradigm in drug discovery
Jose L. Medina-Franco et al.
DRUG DISCOVERY TODAY (2013)
Phenotypic screens as a renewed approach for drug discovery
Wei Zheng et al.
DRUG DISCOVERY TODAY (2013)
A Repurposing Approach Identifies Off-Patent Drugs with Fungicidal Cryptococcal Activity, a Common Structural Chemotype, and Pharmacological Properties Relevant to the Treatment of Cryptococcosis
Arielle Butts et al.
EUKARYOTIC CELL (2013)
Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non-Small Cell Lung Cancer
Rui Li et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Target identification and mechanism of action in chemical biology and drug discovery
Monica Schenone et al.
NATURE CHEMICAL BIOLOGY (2013)
Topical Paromomycin with or without Gentamicin for Cutaneous Leishmaniasis
Afif Ben Salah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Fungal Infections Associated with Contaminated Methylprednisolone Injections
Carol A. Kauffman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Toward Repurposing Ciclopirox as an Antibiotic against Drug-Resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae
Kimberly M. Carlson-Banning et al.
PLOS ONE (2013)
Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity
Francesco Imperi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Combination approaches to combat multidrug-resistant bacteria
Roberta J. Worthington et al.
TRENDS IN BIOTECHNOLOGY (2013)
Identification of the factors that result in obviousness rulings for biotech patents An updated analysis of the US Federal Circuit decisions after KSR
Fangyu Lin et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Drug repurposing a reality: from computers to the clinic
Naiem T. Issa et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2013)
The Antidepressant Sertraline Provides a Promising Therapeutic Option for Neurotropic Cryptococcal Infections
Bing Zhai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Metabolic network analysis predicts efficacy of FDA-approved drugs targeting the causative agent of a neglected tropical disease
Arvind K. Chavali et al.
BMC SYSTEMS BIOLOGY (2012)
Repurposing Approved and Abandoned Drugs for the Treatment and Prevention of Cancer through Public-Private Partnership
Scott J. Weir et al.
CANCER RESEARCH (2012)
Phase I Study of the Antiangiogenic Antibody Bevacizumab and the mTOR/Hypoxia-Inducible Factor Inhibitor Temsirolimus Combined with Liposomal Doxorubicin: Tolerance and Biological Activity
John Moroney et al.
CLINICAL CANCER RESEARCH (2012)
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
Florence Robert-Gangneux et al.
CLINICAL MICROBIOLOGY REVIEWS (2012)
Drug Screen Targeted at Plasmodium Liver Stages Identifies a Potent Multistage Antimalarial Drug
Filipa P. da Cruz et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target
Anjan Debnath et al.
NATURE MEDICINE (2012)
Drug repurposing programmes get lift off
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2012)
Ten Common Questions (and Their Answers) About Off-label Drug Use
Christopher M. Wittich et al.
MAYO CLINIC PROCEEDINGS (2012)
TDR Targets: a chemogenomics resource for neglected diseases
Maria P. Magarinos et al.
NUCLEIC ACIDS RESEARCH (2012)
Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis
P. P. Simarro et al.
PARASITOLOGY (2012)
Identifying mechanism-of-action targets for drugs and probes
Elisabet Gregori-Puigjane et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Liver-stage malaria parasites vulnerable to diverse chemical scaffolds
Emily R. Derbyshire et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Tracking a Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae with Whole-Genome Sequencing
Evan S. Snitkin et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Niclosamide Is a Proton Carrier and Targets Acidic Endosomes with Broad Antiviral Effects
Andreas Jurgeit et al.
PLOS PATHOGENS (2012)
Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics
Martin Schulz et al.
CRITICAL CARE (2012)
Short Report: Amebiasis-Related Mortality among United States Residents, 1990-2007
Janelle Gunther et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Doxycycline for Malaria Chemoprophylaxis and Treatment: Report from the CDC Expert Meeting on Malaria Chemoprophylaxis
Kathrine R. Tan et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
High-Throughput Giardia lamblia Viability Assay Using Bioluminescent ATP Content Measurements
Catherine Z. Chen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Discriminating lymphomas and reactive lymphadenopathy in lymph node biopsies by gene expression profiling
To Ha Loi et al.
BMC MEDICAL GENOMICS (2011)
A Phase I Trial of Liposomal Doxorubicin, Bevacizumab, and Temsirolimus in Patients with Advanced Gynecologic and Breast Malignancies
John W. Moroney et al.
CLINICAL CANCER RESEARCH (2011)
Plasma protein binding may reduce antimicrobial activity by preventing intra-bacterial uptake of antibiotics, for example clindamycin
A. Burian et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole
Michaela Spitzer et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
Linda Ejim et al.
NATURE CHEMICAL BIOLOGY (2011)
PROMISCUOUS: a database for network-based drug-repositioning
Joachim von Eichborn et al.
NUCLEIC ACIDS RESEARCH (2011)
Niclosamide Suppresses Cancer Cell Growth By Inducing Wnt Co-Receptor LRP6 Degradation and Inhibiting the Wnt/β-Catenin Pathway
Wenyan Lu et al.
PLOS ONE (2011)
The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical Genomics
Ruili Huang et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain production
F. L. Khanim et al.
BLOOD CANCER JOURNAL (2011)
Discovery of Potent Small-Molecule Inhibitors of Multidrug-Resistant Plasmodium falciparum Using a Novel Miniaturized High-Throughput Luciferase-Based Assay
Edinson Lucumi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Image-Based High-Throughput Drug Screening Targeting the Intracellular Stage of Trypanosoma cruzi, the Agent of Chagas' Disease
Juan C. Engel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Pentamidine inhibits Coxiella burnetii growth and 23S rRNA intron splicing in vitro
Michael F. Minnick et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Repurposing FDA-approved drugs to combat drug-resistant Acinetobacter baumannii
Sidharth Chopra et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Polymyxin B, in combination with fluconazole, exerts a potent fungicidal effect
Bing Zhai et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Steven M. Paul et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Gene Expression Signature-Based Screening Identifies New Broadly Effective Influenza A Antivirals
Laurence Josset et al.
PLOS ONE (2010)
Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection
Pablo Gastaminza et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle
Karuppiah Chockalingam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Optimal Drug Synergy in Antimicrobial Treatments
Joseph Peter Torella et al.
PLOS COMPUTATIONAL BIOLOGY (2010)
Antifungal Activity of Tamoxifen: In Vitro and In Vivo Activities and Mechanistic Characterization
Kristy Dolan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Outer membrane permeability and antibiotic resistance
Anne H. Delcour
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2009)
Coordination Chemistry Based Approach to Lipophilic Inhibitors of 1-Deoxy-D-xylulose-5-phosphate Reductoisomerase
Lisheng Deng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Synergistic drug combinations tend to improve therapeutically relevant selectivity
Joseph Lehar et al.
NATURE BIOTECHNOLOGY (2009)
Drug Discovery Using Chemical Systems Biology: Repositioning the Safe Medicine Comtan to Treat Multi-Drug and Extensively Drug Resistant Tuberculosis
Sarah L. Kinnings et al.
PLOS COMPUTATIONAL BIOLOGY (2009)
Revisiting the host as a growth medium
Stacie A. Brown et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Pentamidine binds to tRNA through non-specific hydrophobic interactions and inhibits aminoacylation and translation
Tao Sun et al.
NUCLEIC ACIDS RESEARCH (2008)
A high-throughput screening assay for small molecules that disrupt yeast cell integrity
Damian J. Krysan et al.
JOURNAL OF BIOMOLECULAR SCREENING (2008)
DrugBank: a knowledgebase for drugs, drug actions and drug targets
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2008)
Antifungal chemical compounds identified using a C-elegans pathogenicity assay
Julia Breger et al.
PLOS PATHOGENS (2007)
In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
S. Ekins et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Innovation - The Connectivity Map: a new tool for biomedical research
Justin Lamb
NATURE REVIEWS CANCER (2007)
Drugs for bad bugs: confronting the challenges of antibacterial discovery
David J. Payne et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast
Ainslie B. Parsons et al.
CELL (2006)
A clinical drug library screen identifies astemizole as an antimalarial agent
Curtis R. Chong et al.
NATURE CHEMICAL BIOLOGY (2006)
Global mapping of pharmacological space
Gaia V. Paolini et al.
NATURE BIOTECHNOLOGY (2006)
Searching for new antimalarial therapeutics amongst known drugs
Jennifer L. Weisman et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2006)
Statistical practice in high-throughput screening data analysis
N Malo et al.
NATURE BIOTECHNOLOGY (2006)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Impact of plasma protein binding on antimicrobial activity using time-killing curves
MA Zeitlinger et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Pharmacokinetics and pharmacodynamics of entacapone and tolcapone after acute and repeated administration:: A comparative study in the rat
M Forsberg et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Antifungal activity in Saccharomyces cerevisiae is modulated by calcium signalling
T Edlind et al.
MOLECULAR MICROBIOLOGY (2002)
Antifungal activity against Candida species of the selective serotonin-reuptake inhibitor, sertraline
C Lass-Flörl et al.
CLINICAL INFECTIOUS DISEASES (2001)
Antifungal properties of selective serotonin reuptake inhibitors against Aspergillus species in vitro
C Lass-Flörl et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
分享论文
